Hultman et al., 2014 - Google Patents
Experimental teratoma: at the crossroad of fetal-and onco-developmentHultman et al., 2014
View PDF- Document ID
- 5099345601802297247
- Author
- Hultman I
- Björk L
- Blomberg E
- Sandstedt B
- Ährlund-Richter L
- Publication year
- Publication venue
- Seminars in cancer biology
External Links
Snippet
Xenografting is the so far only available in vivo model for assessing pluripotency of human stem cells. This review describes known biological features of experimental teratoma from human pluripotent stem cells. We focus on the dual nature mimicking both normal and …
- 206010043276 Teratoma 0 title abstract description 43
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Buta et al. | Reconsidering pluripotency tests: do we still need teratoma assays? | |
| Singh et al. | Describing the stem cell potency: the various methods of functional assessment and in silico diagnostics | |
| Wobus et al. | Present state and future perspectives of using pluripotent stem cells in toxicology research | |
| Baker et al. | Capturing totipotent stem cells | |
| Suzuki et al. | What has single-cell RNA-seq taught us about mammalian spermatogenesis? | |
| Melton | ‘Stemness’: definitions, criteria, and standards | |
| Park et al. | Derivation of primordial germ cells from human embryonic and induced pluripotent stem cells is significantly improved by coculture with human fetal gonadal cells | |
| Etzrodt et al. | Quantitative single-cell approaches to stem cell research | |
| Chen et al. | Generation of cynomolgus monkey chimeric fetuses using embryonic stem cells | |
| Grabarek et al. | Differential plasticity of epiblast and primitive endoderm precursors within the ICM of the early mouse embryo | |
| Gropp et al. | Standardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progeny | |
| Bungum | Sperm DNA integrity assessment: a new tool in diagnosis and treatment of fertility | |
| Diaz Perez et al. | Derivation of new human embryonic stem cell lines reveals rapid epigenetic progression in vitro that can be prevented by chemical modification of chromatin | |
| Gontan et al. | REX1 is the critical target of RNF12 in imprinted X chromosome inactivation in mice | |
| Rugg-Gunn et al. | Technical challenges of studying early human development | |
| Yao et al. | Stem cell toxicology: a powerful tool to assess pollution effects on human health | |
| Hultman et al. | Experimental teratoma: at the crossroad of fetal-and onco-development | |
| De Santis et al. | The emergence of human gastrulation upon in vitro attachment | |
| Zhang et al. | In vitro developmental toxicology screens: a report on the progress of the methodology and future applications | |
| Paterson et al. | Characterization of companion animal pluripotent stem cells | |
| Ebner et al. | Time-lapse imaging provides further evidence that planar arrangement of blastomeres is highly abnormal | |
| Liu et al. | Human blastoid as an in vitro model of human blastocysts | |
| Andrews | Human pluripotent stem cells: tools for regenerative medicine | |
| David et al. | An update on human pre-and peri-implantation development: a blueprint for blastoids | |
| Sozen et al. | Pluripotent cell states and fates in human embryo models |